News Pain Therapeutics' opioid drug fails to gain FDA approval The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time.
News FDA refuses to approve Insys opioid painkiller The US regulators have rejected Insys Therapeutics' opioid-based painkiller because of concerns about its safety.
Partner Content Partner Content Pain Therapeutics conference is taking place in London next ... SMi Group reports: To reserve last available seats at the Pain Therapeutics Conference, head on to the event website http://www.pain-therap
News FDA approves Indivior's long-lasting opioid withdrawal thera... Monthly injection will help addicts manage withdrawal symptoms
News FDA delays decision on abuse deterrence data on Endo painkil... Data could be used to fend off generic competition.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
